Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

CRBU Caribou Biosciences Inc

3,54

-0,05 (-1,39%)

18 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Caribou Biosciences (NASDAQ:CRBU)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Caribou Biosciences Charts.

Caribou Biosciences (NASDAQ:CRBU)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Caribou Biosciences Charts.

News Caribou Biosciences Inc

Form 8-K - Current report
Dienstag 7 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
Dienstag 7 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Caribou Biosciences to Participate in Upcoming Investor Conferences
Mittwoch 1 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Mittwoch 24 April 2024 (4 Wochen vor) • GlobeNewswire Inc.

Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
Montag 15 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus
Donnerstag 4 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Montag 11 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Montag 11 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 11 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Montag 11 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting
Dienstag 5 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 22 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Caribou Biosciences Inc News-Artikel

HCM Acquisition

Karsan Automotive Indust... (PK)

iShares NASDAQ Biotechno...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen